Medicine and Dentistry
Fracture
100%
Sclerostin
100%
Osteolysis
75%
Ossification
75%
Therapeutic Procedure
62%
Multiple Myeloma
50%
Antibody
37%
Bone Mass
37%
Myeloma
37%
Osteocyte
37%
Antagonist
25%
Neoplasm
25%
Bone Disease
25%
Plasma Cell
25%
Zoledronic Acid
25%
Patient
25%
Protein
12%
Malignant Neoplasm
12%
Osteoblast
12%
Myeloma Cell
12%
Bisphosphonate
12%
Development
12%
Bone Lesion
12%
Bone Destruction
12%
Myeloma Cell Line
12%
Skeleton
12%
Biochemistry, Genetics and Molecular Biology
Sclerostin
100%
Bone
100%
Osteolysis
75%
Ossification
75%
Osteocyte
37%
Bone Mass
37%
Antibody
37%
Mouse
25%
Plasma Cell
25%
Osteoblast
12%
Development
12%
Tumor Volume
12%
Contrast
12%
Protein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sclerostin
100%
Fracture
62%
Multiple Myeloma
50%
Antibody
37%
Myeloma
37%
Neoplasm
25%
Mouse
25%
Bone Disease
25%
Zoledronic Acid
25%
Protein
12%
Malignant Neoplasm
12%
Bisphosphonic Acid Derivative
12%
Bone Destruction
12%
Bone Lesion
12%